Opioid δ-receptor agonists show promise for treating IBS-like symptoms

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and reducing stress-induced hypermotility.

The value of CNS-specific eCOA provider in clinical trials – Pharmaceutical Technology

CNS assessments should be a consideration for all clinical trials, not just those that are CNS-based. Credit: ESB Professional via Shutterstock. The pharmaceutical industry is

September 4, 2024

A guide to long-term care insurance

If you’re wealthy, you’ll be able to afford help in your home or care in an assisted living facility or a nursing home. If you’re

November 22, 2023

A Sign of Trouble for the MSOs

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.